System 001 — InteractOR
Surgeons leave the sterile field to touch a screen.
We made the touch unnecessary.
Zero hardware · Software only · A Plunia system
86M
Minimally invasive surgeries per year, worldwide
10 → 1
Minutes per intraoperative imaging consultation
~$36B
Potential annual OR time savings
0
Hardware added to the operating room
/ 01 — See it work
InteractOR — 90 second demo
/ 02 — The problem
Mid-surgery, the patient's imaging sits on a screen the surgeon cannot touch.
9.8
Distractions per hour in the operating room — driving surgical errors, infections and skipped safety checks.
Antoniadis et al., J Surg Res, 2014
45%
Of surgeons report feeling distracted during the operation itself.
Jung et al., Surg Endosc, 2020
$46–133
Cost of a single minute in a US operating room. Every imaging consultation today burns ten of them.
Childers & Maggard-Gibbons, JAMA Surgery, 2018
/ 03 — The system
The instruments already in the surgeon's hands become the interface.
/ See
Real-time instrument recognition
Our AI model identifies the surgical instruments live in the endoscopic video — no markers, no sensors, no calibration step.
/ Map
Configurable interaction layer
Tool gestures map to interface actions through a reconfigurable layer — the core of our patented approach.
/ Interact
Imaging, inside the view
Preoperative MRI and CT are browsed as an image overlay on the live endoscopic feed — the sterile field stays intact.
Ten minutes of imaging consultation → one. Without anyone leaving the table.
510(k)
FDA pathway · Class II
Patent filed
2026 · Core interaction layer
CHI 2026
Peer-reviewed publication
ISIR · CNRS
Sorbonne Université spin-off
/ 04 — The team
Three researchers who refused to let the technology sleep.
Photo — Nour
Nour Karoui
Chief Executive Officer · Co-founder
PhD candidate at ISIR (Sorbonne Université / CNRS). Three years adapting the technology to the operating room's constraints — not the other way around.
LinkedIn ↗
Photo — Yara
Yara Ibrahim
Chief Technology Officer · Co-founder
PhD candidate at ISIR (Sorbonne Université / CNRS). Leads the technology and the regulatory architecture, from model to FDA submission.
LinkedIn ↗
Photo — Alex
Alex Martinez Lopez
Chief Business Officer · Co-founder
PhD candidate in Neuroscience at the University of Pennsylvania. President of the Penn Biotech Group. Builds the bridge to the US market.
LinkedIn ↗
/ 05 — Advisory board
Guided by people who have been there.
First advisor
To be announced · 2026
/ Get in touch
We are licensing the sterile interaction layer to the OEMs building tomorrow's surgical stack. Let's talk.